1 Beaten-Down Stock That Could Soar by 50% in 2025, According to Wall Street monthlywealthstream
Biotech giant Regeneron Pharmaceuticals (NASDAQ: REGN) started 2024 on a strong note and performed well through the first half of the year. However, the drugmaker has since seen its shares decline substantially due to several factors, most notably headwinds related to one of its key growth drivers (more on that later). Still, many analysts on […]